The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The U.S. Food and Drug Administration (FDA) has approved a new pain pill called Journavx, designed to mitigate the risks of addiction and overdose associated with opioid medications like Vicodin and ...
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.